BIS Research ( Business Intelligence and Strategy Research)

  According to a new market intelligence report by BIS Research titled ‘ Global Liquid Biopsy Market – Analysis and Forecast, 2020-2030 ’ , The liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030 BIS Research Report: https://bisresearch.com/industry-report/global-liquid-biopsy-market.html   Liquid biopsy can be used as a better alternative for treatment and recurrence monitoring as these biopsies overcome invasive biopsy challenges of taking a tumor sample again and again during the course of the treatment. Liquid biopsies existing features, such as non-invasiveness, real-time monitoring, and diagnosis of mutations with the use of mere one sample have provided them a widespread utility among physicians.   Currently, tissue-based biopsy is considered as a standard protocol for the cancer diagnosis worldwide, however the process is considered costly and comes up w...

With the rising incidence of chronic and lifestyle diseases in people, the demand for diagnostic tests is also increasing in the healthcare industry . With more and more people dying with cancer every day and more people getting affected, diagnostics services for cancer must be improved. Biopsy is the most common test conducted to check the presence of cancer biomarkers in a body. Based on the type of cancer a patient is suffering from, the doctor performs the biopsy which is suitable for the cancer type. Normally, a tissue biopsy is considered wherein a sample of the tissue is extracted from the body to test the presence of cancerous biomarkers. However, this is a minimally invasive procedure, a small incision is made to extract the affected tissue from the body. Organizations as on date are conducting extensive research to develop new ways to detect cancer and subsequently identify the ways it can be treated. One such way to diagnose cancer is through liquid biopsy. It is a n...